BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chris Bellamy, Alastair D. Burt. Macsween's Pathology of the Liver2018; : 966 doi: 10.1016/B978-0-7020-6697-9.00015-7
2
A. Oruc, A. Ersoy. Transplantation Opportunities of Hepatitis C Virus–Seropositive Patients on the Kidney Waiting ListTransplantation Proceedings 2018; 50(10): 3181 doi: 10.1016/j.transproceed.2018.04.044
3
Pavlina Dzekova-Vidimliski, Aleksandar Sikole. Hepatitis C Virus Infection in Maintenance Hemodialysis Patients: Recommendations for Diagnostics and TreatmentThe International Journal of Artificial Organs 2016; 39(12): 590 doi: 10.5301/ijao.5000548
4
Ladan Golestaneh, Joel Neugarten. Dual Organ Duel: The Hepatorenal AxisAdvances in Chronic Kidney Disease 2017; 24(4): 253 doi: 10.1053/j.ackd.2017.05.009
5
Byung Seok Lee, Myeong Jun Song, Jung Hyun Kwon, Tae Hee Lee, Ji Woong Jang, Seok Hyun Kim, Sae Hwan Lee, Hong Soo Kim, Ji Hoon Kim, Seok Bae Kim, Soon Young Ko, Do Seon Song. Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on HemodialysisGut and Liver 2019; 13(2): 191 doi: 10.5009/gnl18240
6
Sean M. McConachie, Sheila M. Wilhelm, Pramodini B. Kale-Pradhan. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvirExpert Review of Clinical Pharmacology 2016; 9(2): 287 doi: 10.1586/17512433.2016.1129272
7
Arogundade F. Abiola. Chronic Kidney Disease in Disadvantaged Populations2017; : 191 doi: 10.1016/B978-0-12-804311-0.00020-0
8
Natasha Silva Constancio, Maria Lucia Gomes Ferraz, Carmen Tzanno Branco Martins, Angiolina Campos Kraychete, Paulo Lisboa Bitencourt, Marcelo Mazza do Nascimento. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approachBrazilian Journal of Nephrology 2019;  doi: 10.1590/2175-8239-jbn-2018-0177
9
Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Tadashi Ikegami, Noritomo Shimada, Keizo Kato, Hiroshi Abe, Tomomi Okubo, Norio Itokawa, Chisa Kondo, Shigeru Mikami, Toru Asano, Yoshimichi Chuganji, Yasushi Matsuzaki, Hidenori Toyoda, Takashi Kumada, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri. Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney diseaseHepatology Research 2018; 48(7): 549 doi: 10.1111/hepr.13058
10
Jakeline Ribeiro Barbosa, Vanessa Faria Cortes, Moyra Machado Portilho, Juliana Custódio Miguel, Vanessa Alves Marques, Cristianne Sousa Bezerra, Natalia Vasconcelos de Souza, Danielle Malta Lima, Jeová Keny Baima Colares, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patientsJournal of Clinical Pathology 2018; 71(10): 879 doi: 10.1136/jclinpath-2018-205024
11
E. Morales, J.M. Cánovas, T. Cavero, P. Auñón, E. Gutiérrez. Afectación renal en las vasculitis, el lupus eritematoso y las enfermedades sistémicasMedicine - Programa de Formación Médica Continuada Acreditado 2015; 11(82): 4902 doi: 10.1016/j.med.2015.06.012
12
Anita Kohli, Ali Alshati, Fawaz Georgie, Richard Manch, Robert G. Gish. Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney diseaseTherapeutic Advances in Gastroenterology 2016; 9(6): 887 doi: 10.1177/1756283X16665254
13
Chisa Kondo, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Toru Asano, Kai Yoshizawa, Tomomi Okubo, Yoshimichi Chuganji, Yoshio Aizawa, Etsuko Iio, Yasuhito Tanaka, Katsuhiko Iwakiri. Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney diseaseHepatology Research 2017; 47(11): 1165 doi: 10.1111/hepr.12879
14
Adriana Dejman, Marco A. Ladino, David Roth. Treatment and management options for the hepatitis C virus infected kidney transplant candidateHemodialysis International 2018; 22: S36 doi: 10.1111/hdi.12646
15
Adele Schwartz Benzaken, Renato Girade, Elisa Catapan, Gerson Fernando Mendes Pereira, Elton Carlos de Almeida, Simone Vivaldini, Neide Fernandes, Homie Razavi, Jonathan Schmelzer, Maria Lucia Ferraz, Paulo Roberto Abrão Ferreira, Mario Guimarães Pessoa, Ana Martinelli, Francisco José Dutra Souto, Nick Walsh, Maria Cassia Mendes-Correa. Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approachThe Brazilian Journal of Infectious Diseases 2019; 23(3): 182 doi: 10.1016/j.bjid.2019.04.010
16
Joel Neugarten, Ladan Golestaneh. Chronic Renal Disease2020; : 863 doi: 10.1016/B978-0-12-815876-0.00053-X
17
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivalsWorld Journal of Clinical Cases 2019; 7(11): 1270-1281 doi: 10.12998/wjcc.v7.i11.1270
18
Jolanta Malyszko, Jacek Zawierucha, Wojciech Marcinkowski, Tomasz Prystacki, Teresa Dryl-Rydzynska, Jacek S. Malyszko, Joanna Matuszkiewicz-Rowinska. The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 yearsInternational Urology and Nephrology 2018; 50(8): 1555 doi: 10.1007/s11255-018-1897-7
19
Hideki Fujii, Hiroyuki Kimura, Masayuki Kurosaki, Chitomi Hasebe, Takehiro Akahane, Hitoshi Yagisawa, Keizo Kato, Hideo Yoshida, Jun Itakura, Shinya Sakita, Takashi Satou, Kazuhiko Okada, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Atsuhiro Morita, Akihiro Nasu, Takashi Tamada, Hiroaki Okushin, Haruhiko Kobashi, Keiji Tsuji, Kouji Joko, Chikara Ogawa, Yasushi Uchida, Akeri Mitsuda, Tetsuro Sohda, Yasushi Ide, Namiki Izumi. Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysisHepatology Research 2018; 48(9): 746 doi: 10.1111/hepr.13070
20
Pavlina Dzekova-Vidimliski, Igor G. Nikolov, Nadica Matevska-Geshkovska, Sami Mena, Lionel Rostaing, Aleksandar Dimovski, Aleksandar Sikole. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patientsRenal Failure 2015; 37(7): 1180 doi: 10.3109/0886022X.2015.1061872
21
Soon Young Ko, Won Hyeok Choe. Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antiviralsClinical and Molecular Hepatology 2018; 24(4): 351 doi: 10.3350/cmh.2017.0063